Skip to main content

Table 1 Specific criteria for assessment of clinical efficacy parameters and scoring system

From: The evaluation of three treatment protocols using oral prednisone and oral meloxicam for therapy of canine idiopathic lymphoplasmacytic rhinitis: a pilot study

Clinical examination parameter

Description

Score

Final overall score of clinical signs

Composition of discharge

Absent

0

0–2 (−) absent

3–5 (+) mild

6–9 (++) moderate

9 (+++) severe

Serous/ sero-mucous

1

Mucous/ sero- purulent

2

Purulent/ muco-purulent/ haemorrhagic

3

Frequency and intensity of discharge

Absent

0

Rare < 2 times/week, mild

1

Frequent > 2 times/week, moderate

2

Continuous, severe

3

Other clinical signs (nasal stridor, reverse sneezing etc)

Absent

0

Rare < 2 times/week, mild

1

Frequent > 2 times/week, moderate

2

Continuous, severe

3